How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
QA Dosimeter Market
- By Dosimeter Type: Passive Dosimeters, Active Dosimeters, Electronic Personal Dosimeters (EPDs), Thermoluminescent Dosimeters (TLDs), Optically Stimulated Luminescence Dosimeters (OSLDs)
- By Radiation Type Detected: Gamma Radiation Dosimeters, X-Ray Dosimeters, Beta Radiation Dosimeters, Neutron Dosimeters, Alpha Radiation Dosimeters
- By End-User Industry: Healthcare and Medical Imaging, Nuclear Power Plants, Industrial Radiography, Research Laboratories, Defense and Military
- By Measurement Parameter: Dose Rate Measurement, Cumulative Dose Measurement, Real-Time Dose Monitoring, Environmental Radiation Monitoring
- By Technology: Solid-State Detectors, Gas-Filled Detectors, Scintillation Detectors, Semiconductor Detectors
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Passive Dosimeters leads By Dosimeter Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.182 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.190 →
Full report · locked preview
Everything inside the QA Dosimeter Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Dosimeter Type 5
Radiation Type Detected 5
End-User Industry 5
Measurement Parameter 4
Technology 4
Companies profiled
Landauer Inc.
Mirion Technologies Inc.
Thermo Fisher Scientific Inc.
RADOS Technology Oy
Radcal Corporation
Fluke Biomedical
PTW-Freiburg GmbH
Nuclear Enterprises Ltd.
Biodex Medical Systems Inc.
IBA Dosimetry
Ludlum Measurements Inc.
Polimaster Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Landauer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Mirion Technologies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →RADOS Technology Oy
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Radcal Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Fluke Biomedical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →PTW-Freiburg GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nuclear Enterprises Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Biodex Medical Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →IBA Dosimetry
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Ludlum Measurements Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Polimaster Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →RadEye (Thermo Fisher Scientific brand)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →DoseVue
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Radcal
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$6,626M by 2033 · 6.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Passive Dosimeters49.0
- Active Dosimeters10.7
- Electronic Personal Dosimeters (EPDs)14.1
- Thermoluminescent Dosimeters (TLDs)9.0
- Optically Stimulated Luminescence Dosimeters (OSLDs)17.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,371M → $2,189M · 6.0%
Europe$955.3M → $1,568M · 6.4%
Asia Pacific$872.2M → $1,365M · 5.8%
Latin America$539.9M → $830.9M · 5.5%
Middle East and Africa$415.3M → $744.5M · 7.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.962026
5.982027
5.992028
5.992029
6.022030
6.032031
6.042032
6.062033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Landauer Inc.15.9
- Mirion Technologies Inc.22.9
- Thermo Fisher Scientific Inc.8.2
- RADOS Technology Oy6.6
- Radcal Corporation9.1
- Fluke Biomedical9.2
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Dosimeter Type33.8%
Radiation Type Detected23.8%
End-User Industry13.1%
Measurement Parameter15.6%
Technology13.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe23.4
- Asia Pacific20.4
- Latin America12.4
- Middle East and Africa11.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Landauer Inc. | 76 | 88 | 83 | 94 | 93 | 79 | 86 |
| Mirion Technologies Inc. | 90 | 84 | 73 | 77 | 84 | 84 | 82 |
| Thermo Fisher Scientific Inc. | 72 | 71 | 83 | 82 | 77 | 66 | 75 |
| RADOS Technology Oy | 81 | 80 | 71 | 64 | 81 | 71 | 75 |
| Radcal Corporation | 57 | 76 | 70 | 66 | 55 | 72 | 66 |
| Fluke Biomedical | 68 | 60 | 56 | 48 | 68 | 54 | 59 |
| PTW-Freiburg GmbH | 65 | 59 | 50 | 52 | 45 | 42 | 52 |
| Nuclear Enterprises Ltd. | 47 | 47 | 36 | 58 | 43 | 38 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Landauer Inc.
- Mirion Technologies Inc.
- Thermo Fisher Scientific Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Landauer Inc. | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Mirion Technologies Inc. | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| RADOS Technology Oy | ◐ | ◐ | ◐ | ✓ | ✓ | ◐ |
| Radcal Corporation | − | ◐ | ✓ | ◐ | − | ✓ |
| Fluke Biomedical | ✓ | ◐ | − | ◐ | ◐ | − |
| PTW-Freiburg GmbH | ◐ | ◐ | − | − | ◐ | ◐ |
| Nuclear Enterprises Ltd. | ◐ | ◐ | − | ◐ | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Landauer Inc.86
2Mirion Technologies Inc.82
3Thermo Fisher Scientific Inc.75
4RADOS Technology Oy75
5Radcal Corporation66
6Fluke Biomedical59
7PTW-Freiburg GmbH52
8Nuclear Enterprises Ltd.45
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Landauer Inc.Mirion Technologies Inc.
Challenger2
Strong scale, closing on the leaders.
Thermo Fisher Scientific Inc.RADOS Technology Oy
Contender2
Focused players with pockets of strength.
Radcal CorporationFluke Biomedical
Niche2
Specialists in a single segment or region.
PTW-Freiburg GmbHNuclear Enterprises Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Dosimeter Type in North America, then scale across QA Dosimeter Market — a $226M beachhead inside a $3.99B market.
Beachhead (SOM)$226Mobtainable near-term
Serviceable (SAM)$1.59Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Passive Dosimeters
Best fit — highest urgency & budget in Dosimeter Type.
Economic buyer75 fit
Active Dosimeters
Strong fit — clear ROI and a fast path to value.
End user69 fit
Electronic Personal Dosimeters (EPDs)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Dosimeter Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Radiation Type Detected & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-User Industry
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Dosimeter Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win QA Dosimeter Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation13%
Closed-won7%
$15.5KCAC
$86KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
QA Dosimeter Market is a resilient opportunity — $1.92B by 2033, compounding at 5.1%.
TAM · 2025$1.29Btoday
TAM · 2033$1.92Bforecast
CAGR5.1%2027–2033
Cumulative$14.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.92BTotal addressable market
SAM$780MServiceable available market
SOM$165MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Dosimeter Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Dosimeter Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.92BLarge & growingTAM by 2033 at 5.1% CAGR
$780MServiceable nowreachable with today’s model
$165MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.50BBear3.3% CAGR
$1.92BBase5.1% CAGR
$2.46BBull6.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Radiation Type Detected optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
QA Dosimeter Market — a $6.97B market by 2033. Plan: grow share from 9.7% to 17.9%.
Market size · 2033$6.97Btotal addressable
Market CAGR5.7%2027–2033
Target share17.9%from 9.7% today
Revenue ambition$1.25Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 17.9% | At risk |
| Revenue | $634M | $1.25B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 29.2% | 39.1% | On track |
| Customer retention | 91.2% | 95.3% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Dosimeter Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Radiation Type Detected capability
A defensible second engine — invest in Radiation Type Detected to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Dosimeter Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Radiation Type Detected
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $137M capacity & capability investment
- Greenlight bolt-on M&A in Radiation Type Detected
- Authorise North America expansion plan
- Fund R&D program for Dosimeter Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the QA Dosimeter Market conversation — a $698M market you can size, segment and defend in minutes.
Market size · 2033$698Mtotal opportunity
Growth3.4%CAGR to 2033
Addressable buyers1,111+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Dosimeter Type
Goal Grow share in Dosimeter Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$46K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Landauer Inc.Mirion Technologies Inc.Thermo Fisher Scientific Inc.RADOS Technology OyRadcal CorporationFluke BiomedicalPTW-Freiburg GmbHNuclear Enterprises Ltd.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your QA Dosimeter Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
QA Dosimeter Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Q10 Antibody Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportPyrvinium Pamoate Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportPyrroloquinoline Quinone Disodium (PQQ) Salt Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportPyrroloquinoline Quinone Disodium (PQQ) Market
Pyrroloquinoline Quinone Disodium (PQQ) Market is valued at USD 62 Million in 2025 and is expec…
$62M market · 2025 base year
View reportPyrimethamine Tablets Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportPyrilamine Maleate Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportPyridoxine Tris-Hexyldecanoate Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportPyridoxine Hydrochloride Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportPyridoxal Phosphate Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportPyridoxal 5'-Phosphate Monohydrate Market
Market size, share, segmentation and regional forecast.
$425M market · 2025 base year
View reportPyridostigmine Bromide API Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportPyrazinamide Tablets Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.